Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Seadrill New Finance Limited (the “Issuer”) – Launch of Chapter 11 Solicitation

Hamilton, Bermuda | December 8, 2021- Seadrill Limited (“Seadrill” or the “Company”) (OSE: SDRL, OTCPK:SDRLF) and the Issuer announce, further to previous announcements made by Seadrill and the Issuer including on July 2, 2021, the launch of solicitation of votes in respect of the Issuer’s chapter 11 plan of reorganisation (the “Plan”).  Following solicitation, the Issuer and certain of its subsidiaries intend to file pre-packaged chapter 11 cases in the US Bankruptcy Court for the Southern District of Texas (the “Bankruptcy Court”) and seek approval of the Plan. The key terms of the

Cloudberry Clean Energy ASA | Successful Completion of NOK 600 million Private Placement

NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OF AMERICA AND THE DISTRICT OF COLUMBIA) (THE "UNITED STATES"), AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL Reference is made to the stock exchange notice published on 8 December 2021 regarding the contemplated private placement of new shares (

Nordea Bank Abp: Repurchase of own shares on 08.12.2021

Nordea Bank AbpStock exchange release – Changes in company’s own shares08.12.2021 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 08.12.2021 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number of Weighted average Total cost, EUR* **venue (MIC shares price / share, EUR* Code) **XSTO 366,214 10.67 3,905,791.86XHEL 420,330 10.66 4,481,012.03CEUX 371,033 10.67 3,957,438.58AQEU 35,593 10.66

EQT Private Equity to invest in 3Shape, a global leader in digital dentistry

· EQT Private Equity to acquire a minority stake in 3Shape, a global leading player and innovator in digital dentistry focused on intra-oral scanners, CAD and CAM software for dental clinics and the dental lab market  · 3Shape’s products are at the forefront of driving digitalization of dentist workflows, reducing material consumption and improving preventive care and patient outcomes  · 3Shape will leverage the expertise from EQT’s in-house digitalization team, global healthcare sector team, and global advisory network, in its next chapter of growth, focusing on continued

Notification of personal data breach

News release from Vestas Wind Systems A/SAarhus, 08 December 2021 Vestas Wind Systems A/S discovered a cyber security incident on 19 November 2021 which involved external attackers compromising and gaining unauthorised access to data stored on Vestas internal file share systems. The investigation carried out by Vestas has confirmed that personal data has been compromised by the attackers. For further information please see: www.vestas.com/personal-data-notificationAbout VestasVestas is the energy industry’s global partner on sustainable energy solutions. We design,

Noreco: Successful Grant of EUDP Funding from Danish Authorities for CCS Project Bifrost

Oslo, 8 December 2021: Norwegian Energy Company ASA (“Noreco” or the “Company”) is together with its partners in Project Bifrost pleased to announce the successful award of funding under the ‘Energy Technology Development and Demonstration Programme’ (EUDP), a Danish public subsidy scheme. Project Bifrost’s funding request of DKK 75 million was met in full by the Danish authorities and is a key enabler in maturing a CO2 transportation and storage concept in the Danish North Sea. The scope of the project, which commences in 2022, includes the development and selection of the CO2 transport

Getinge enters into a settlement agreement related to the MDL mesh litigation and makes a concluding provision of additional SEK 600 M

Getinge's subsidiary Atrium Medical Corporation has entered into a settlement agreement with plaintiffs’ lead counsel related to the multidistrict litigation (MDL) linked to surgical mesh product liability in the US. An additional provision of SEK 600 M is made to account for the settlement in addition to litigation expenses incurred to date.“I am pleased that we can put this behind us and fully focus on our core business, and delivering on our strategy”, says Mattias Perjos, President & CEO Getinge.   The settlement agreement was today executed to resolve matters pending in the District

Inwido launches new long-term targets with increased ambitions within growth and sustainability

Ahead of Inwido's Capital Markets Day on December 9, new long-term financial targets and developed sustainability ambitions are launched.Inwido's current financial targets were established in connection with the IPO in 2014. Since then the business and profit generation have developed continuously. In the updated targets the Group’s growth ambitions are accelerated, organically as well as through acquisitions. These are the new financial targets decided by the Board: · Growth (revised): Revenue target SEK 20 billion in 2030 · Profitability (revised): >15% return on operating capital

Calmark receives Notice of Allowance regarding patent in USA

Calmark Sweden AB (publ) announces today that the US Patent Office ("USPTO") has issued a Notice of Allowance regarding Calmark's POC system.The patent, entitled "Detection of a biomarker in a sample of a flowable substance" and application number 16/477143, covers the entire POC system and the method of detecting a biomarker in eg blood. The patent provides protection until 2038. The Notice of Allowance means that the USPTO will approve the company's patent application. Including the new patent, Calmark owns seventeen patents and design protection for both the instrument and the test

UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 08.12.2021

United Bankers Corporation NOTIFICATION 08.12.2021 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 08.12.2021 Date 08.12.2021Exchange transaction BuyShare class UNITEDAmount 319Average price/share 13.6818 EURHighest price/share 13.7000 EURLowest price/share 13.6500 EURTotal price 4,364.49 EUR The shares held by United Bankers Corporation on 08.12.2021: UNITED 54,359 On behalf of United Bankers Corporation  Skandinaviska Enskilda Banken AB (Publ) Antti Salakka

BICO wins SwedenBIO Award 2021

BICO has been awarded this year's SwedenBIO Award for showcasing the power of the Swedish life-science industry on the global arena and its visionary business model and remarkable growthThe world-leading bio convergence company, BICO, today announced that it has received SwedenBIO's Award which was announced in connection with SwedenBIO's Annual Summit in Stockholm. Presented for the last fifteen years, the Award honors a life-science company that has shown outstanding achievements and contributions to society and that exemplifies the potential of a strong Swedish life science industry.

Kesko to acquire Kungälvs Trävaruaktiebolag, a company serving professional builders in Sweden

Kesko will acquire Kungälvs Trävaruaktiebolag, thus strengthening its position in the Swedish building and home improvement trade market in the Gothenburg area.Kungälvs Trävaruaktiebolag's net sales in 2020 totalled approximately €32.6 million. The company has four stores in the Gothenburg area, and it employs some 80 people who specialise in serving B2B customers. Kesko continues the implementation of its growth strategy in Northern Europe, where it is the leading operator in building and technical trade. In Sweden, Kesko operates the building and home improvement trade chains K-Rauta

Terveystalo Plc: SHARE REPURCHASE 8.12.2021

Terveystalo Plc ANNOUNCEMENT  8.12.2021 Terveystalo Plc: SHARE REPURCHASE 8.12.2021 In the Helsinki Stock Exchange Trade date           8.12.2021Bourse trade         BuyShare                  TTALOAmount             29 000 SharesAverage price/ share    11,1077 EURTotal cost            322 123,30 EUR Terveystalo Plc now holds a total of 1 367 168 sharesincluding the shares repurchased on 8.12.2021 On behalf of Terveystalo Plc Nordea Bank Oyj Janne

#21-406 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-405 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Composition of Anora’s Shareholders’ Nomination Board

Anora Group Plc   Stock Exchange Release  8 December 2021 at 6:15 pm EET Composition of Anora’s Shareholders’ Nomination Board Anora Group Plc’s three largest shareholders have nominated the following representatives to the Shareholders’ Nomination Board: · Stein Erik Hagen, Canica AS · Petter Söderström, Solidium Oy · Anne Lise E. Gryte, Geveran Trading Co. Limited In its organising meeting on 8 December 2021 the Nomination Board has elected Stein Erik Hagen as its Chairman. Michael Holm Johansen and Sanna Suvanto-Harsaae, Chairman and Vice Chairman of Anora’s Board of

Midsona receives prestigious CDP rating A-

Midsona has been recognized for its climate change strategy and leadership by the global environmental non-profit initiative CDP. By achieving A-, Midsona is ranked among the best listed companies in the world.In 2021, a record-breaking 13,000+ companies representing over 64 percent of global market capitalization responded to CDP’s climate change questionnaire. By achieving A-, Midsona is among the 714 (5,4 percent) best companies globally when it comes to climate change strategy and leadership. The CDP’s annual scoring process is widely considered the gold standard of corporate

Nordic Nanovector to Present at DNB's 12[th] Nordic Healthcare Conference

Oslo, Norway, 8 December 2021 Nordic Nanovector ASA (OSE: NANOV), clinical-stage biotech company focused on CD37-targeted therapies for haematological cancers and immune diseases, announces that its CEO, Erik Skullerud will present a corporate overview via live webcast at DNB's 12[th] Nordic Healthcare Conference  on 16 December 2021. The presentation will take place from 10:15-10:35 CET (CET). The presentation will be available at the same time at www.nordicnanovector.com in the section: Investors & Media/Reports

Cloudberry Clean Energy ASA | Contemplated Private Placement

NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OF AMERICA AND THE DISTRICT OF COLUMBIA) (THE "UNITED STATES"), AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL  Cloudberry Clean Energy ASA (“Cloudberry” or the “Company”) has retained Carnegie AS and Pareto Securities AS as Joint Global

Progressive Grocer Names Chiquita 2021 Category Captain

World’s leading banana company has earned coveted award for more than two decadesFort Lauderdale, FL – December 8, 2021 – For the 22[nd] consecutive year, leading grocery publication Progressive Grocer  has named Chiquita  a 2021 Category Captain, proving the brand’s commitment to delivering the highest quality banana to its loyal fanbase. The Category Captain Awards  recognize overall excellence in innovative, profit-generating category management efforts that help

Self Storage Group ASA - Acquisition of new property in Arendal, Norway

(Oslo, December 8th 2021) Self Storage Group ASA (Self Storage Group, OSE:SSG) has entered into an agreement to acquire a property in Molandsveien 339 in Arendal, Norway. The transaction has a value of NOK 7.1 million. The property has a potential lettable area of 850 square meters. The facility is projected to open in Q4 2022, and will be operated under the OK Minilager brand. "The property is located in Arendal, close to the E-18 highway. With this investment we will strengthen our number one position in the City of Arendal, and the Agder region. This acquisition is in line with our

SimCorp’s Financial Calendar 2022

Company Announcement no. 54/2021 SimCorp A/S has scheduled the following dates in 2022 for the Annual General Meeting, payout of dividend and release of financial reports. February 9, 2022                   Deadline for submission by shareholders of SimCorp of resolutions to be considered by the Annual General Meeting 2022 February 15, 2022                 Publication of Annual Report 2021 (early morning) March 24, 2022                     Annual General Meeting 2022 March 29, 2022                     Expected date for payout of dividend May 19, 2022

BioStock Studio: Cyxone comments on the Covid-19 study results

Biotech company Cyxone has announced results from their phase II trial with drug candidate Rabeximod in patients with moderate to severe Covid-19. The data were inconclusive in terms of the effect of the drug candidate compared to standard of care treatment and Cyxone will now analyse the results further. In parallel, the company is preparing Rabeximod for a coming phase II trial in rheumatoid arthritis, the main focus for the candidate and Cyxone’s leading project. Tara Heitner, CEO, and Carl-Magnus Högerkorp, COO, visited the BioStock Studio to explain.Watch the interview with Cyxone at

There are no items matching the current filter
There are no more items matching the current filter
Back to top